Plain-English translation of NCT05356039 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers will follow your medical care without testing a new drug or procedure—that aims to understand outcomes in people with locally advanced or borderline resectable pancreatic cancer. The study will track how many patients are able to have surgery, how long patients survive, and how their quality of life changes during treatment. By enrolling 300 patients across Nordic hospitals, researchers hope to learn what factors help determine whether surgery is possible and what outcomes patients can expect.
Pancreatic cancer is a serious disease, and doctors need better information about which patients benefit most from surgery and how to support patients' quality of life throughout treatment. This study will help doctors make better decisions about who should have surgery and improve overall care for people with this type of cancer.
You likely qualify if…
You likely don't qualify if…
As a participant, you will continue receiving your normal cancer care at your hospital while researchers collect information about your treatment, outcomes, and quality of life. You will complete surveys about how you are feeling and how the cancer and treatment are affecting your daily activities. The study will follow you over time to track whether surgery becomes possible, how you respond to treatment, and your overall survival.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Sweden
Sponsor
Umeå University
Collaborators
University Hospital, Linkoeping, Lund University Hospital
Enrollment target
~300 participants
Started
April 2022
Primary completion
May 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Oskar Franklin, MD/PhD
Umeå University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.